ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Article

Maternal and newborn seroprevalence of Hepatitis E virus at Medani Hospital, Sudan

[version 1; peer review: 3 approved with reservations]
PUBLISHED 16 Sep 2015
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

Hepatitis E virus (HEV) infection can lead to adverse maternal and perinatal outcomes and is a risk for mortality in pregnant women.  There are few published data on the seroepidemiology of HEV infection in pregnant women and none are available from Sudan specifically. A cross-sectional study was conducted to investigate the seroepidemiology of anti-HEV Immunoglobulin G (IgG) antibodies in mothers and newborns in Medani Hospital, Sudan. Socio-demographic, clinical and obstetric characteristics of the women were gathered using questionnaires. Anti-HEV IgG antibodies were investigated in the paired maternal and newborn sera using an enzyme-linked immunoassay (ELISA). Two hundred and nine women were enrolled to the study. The mean (SD) of their age, parity and gestational age was 27.5 (5.5) years, 2.2(1.5) and 38.8 (1.8) weeks, respectively. Out of these 209, 25 (12.5%) women had a positive result for anti-HEV IgG and two (1.0%) newborns had a positive result for anti-HEV IgG.In logistic regression none of the investigated factors (age, parity, gestational age, residency and education) were associated with anti-HEV IgG seropositivity. There is a high seroprevalence of HEV among pregnant women in central Sudan regardless of their age, parity and gestational age. Optimal preventive measures against HEV infection should be employed.

Keywords

Pregnancy, vertical transmission, HEV, newborn, Sudan

Introduction

Hepatitis E virus (HEV) is a single-stranded RNA virus and an emerging infectious agent where it can cause acute viral hepatitis worldwide with estimated 20 million cases of HEV infection occur globally and 70 000 deaths (Aggarwal & Gandhi, 2010; Rein et al., 2012). Due to hormonal and immunological changes, pregnant women are more prone to have severe form of HEV infections where there is increasing evidence that HEV is an important contributor to maternal and perinatal morbidity and mortality, especially in the developing countries (Ahmed et al., 2008; Bose et al., 2011; Bose et al., 2014; Kumar et al., 2001; Navaneethan et al., 2008; Ornoy & Tenebaum, 2006; Rayis et al., 2013). In previous studies, Stoszek et al. (2006) and Patra et al. (2007) reported prevalence rates of 84.3% and 60% of anti-HEV antibodies among pregnant women in Egypt and India, respectively.

In Sudan, a high mortality rate was reported among pregnant women in an outbreak of HEV in Darfur and in eastern Sudan (Boccia et al., 2006; Rayis et al., 2013). In spite of this there are no published data on the seroprevalence of anti-HEV IgG in Sudan and screening of HEV is not part of the antenatal care programme. Research on the seroprevalence of HEV is of paramount importance for health policy makers as well as for the practicing clinicians and it will yield data necessary for developing preventive measures. This study was conducted to determine the seroprevalence of anti-HEV IgG among a population of pregnant women and their newborns in Medani, Sudan.

Materials and methods

A cross-sectional study was conducted at the delivery ward of Medani Maternity Hospital, Sudan during the period of March 2013. Medani Hospital is a tertiary care hospital in central Sudan, located in Al Gezira state which is the second largest state in Sudan. Women with a singleton pregnancy were approached to be enrolled to the study. Mothers who experienced stillbirths and those who had been diagnosed with diabetes or hypertension were excluded from the current study. After signing an informed consent form, socio-demographic, medical and obstetric characteristics were gathered using a questionnaire that was applied in the local language (Arabic; see Supplementary file 1 for sample questionnaire). A convenience sampling method was used where consecutive eligible women were recruited every day until the total desired sample size was achieved (206). The sample size of 206 women was calculated based on a 2-sided hypothesis test using Epiinfo software (Centre for Disease Control, USA; version 6) that yielded 80% power and a confidence interval of 95% with 10% of women expected to have incomplete data or samples.

Body mass index (BMI) was calculated by maternal weight and height that were measured. Five millilitres of blood was collected from each woman along with the corresponding infants’ umbilical cord. The umbilical cords were stored in plain tubes and all samples were labelled and kept at room temperature for 30 minutes, centrifuged at 2000 rpm for 10 minutes to separate blood components. Serum was stored at -20 degrees until analyzed for anti-HEV IgG using specific antibody profiles using HEV IgG-specific ELISA (Euroimmun, Lübeck, Germany).

Statistics

Data were entered in computer using SPSS software (IBM, UK; version 16) for Windows. Statistics were described as mean (SD) for continuous data and as frequency and percentages (%) for categorized data. T-test and X2 were used to compare continuous and categorized data, respectively between women who were seropositive for HEV IgG antibodies and women with a negative result for HEV antibodies. Binary logistic regression was conducted where seropositivity for HEV IgG antibodies was the dependent variable and socio-demographic, clinical characteristics were the independent variable. Odds ratio and 95% confidence interval were calculated, and P values of < 0.05 were considered statistically significant.

Ethics

Ethical approval was obtained from the Ethical committee of University of Khartoum.

Results

Two hundred and nine women were enrolled in the study. The mean (SD) of their ages, parities and gestational ages were 27.5 (5.5) years, 2.2 (1.5) and 38.8 (1.8) weeks, respectively. Out of these 209, 25 (12.5%) women had a positive result for anti-HEV IgG and two (1.0%) newborns whose mothers also had a positive anti-HEV IgG showed a positive result for anti-HEV IgG.

There was no significant difference in the age, parity, education, gestational age, BMI or history of miscarriage between seropositive and seronegative anti-HEV IgG women (Table 1). Likewise, in logistic regression none of these investigated factors were associated with anti-HEV IgG seropositivity (Table 2).

Table 1. Comparing socio-demographic characteristics between HEV IgG seropositive and seronegative women in Medani, Sudan.

VariablesHEV IgG
seropositive (n= 25)
HEV IgG
seronegative (n=184)
P
Mean (SD) of the
Age, years27.4(5.0)27.5(5.6)0.950
Parity2.0(1.9)2.2(1.4)0.526
Gestational age, weeks38.3(2.5)38.8(1.7)0.217
Body mass index, kg/cm224.6(2.1)23.9(2.9)0.225
Hemoglobin, g/dl9.9(1.0)10.4(1.0)0.008
Number (%) of the
Rural residence12(48.0)101(54.8)0.300
Education < secondary level13(52.0)61(33.1)0.064
History of miscarriage7(28.0)77(41.8)0.270

Table 2. Univariate and multivariate analysis of risk factors and their association with anti-HEV IgG seropositivity among pregnant women in Medani, Sudan.

Univariate AnalysisMultivariate Analysis
CharacteristicsOR95% CIP valueOR95% CIP value
Age0.90.92─1.070.9500.90.85─1.080.572
Parity0.90.67─1.220.5251.30.85─2.070.212
Gestational age0.80.70─1.080.2200.90.72─1.1660.492
Residence1.30.59─3.160.3510.60.20─1.790.370
Educational level< secondary2.160.93─5.030.0723.10.89─10.820.075
History of miscarriage1.830.72─4.640.2011.70.58─5.40.308
Body mass index1.110.94─1.310.2051.10.95─1.450.129
Hemoglobin1.441.00─2.080.0501.40.89─2.300.137
Dataset 1.Raw dataset for Eltayeb et al., 2015 ‘Maternal and newborn seroprevalence of Hepatitis E virus at Medani Hospital, Sudan’.
Socio-demographic, clinical and obstetric characteristics of the women were gathered using questionnaires. Anti-HEV IgG antibodies were investigated in the paired maternal and newborn sera using an enzyme-linked immunoassay (ELISA). Wt=weight (Maternal;kg); Ht=height (Maternal;cm), Hb= haemoglobin(Maternal; g/dl); birthwt=birthweight (Child; kg); bloodgroup (Maternal): 0=A, 1=B, 2=AB 3=O; HepIgGM= Maternal Hepatitis E IgG, 1=positive, 0=negative; HepIgGC=Newborn Hepatitis E IgG, 1=positive, 0=negative. Raw data file openable by PSPP, available at https://www.gnu.org/software/pspp/.

Discussion and conclusions

The main findings of the current study were: the high prevalence (12.1%) of HEV IgG antibodies among pregnant women regardless of their age, parity, residence and educational levels. Recently Caron & Kazanji (2008) found that 14.1% of 840 pregnant women in Gabon had anti-HEV IgG and the prevalence was significantly higher in the urban areas than in the rural ones (13.5 vs. 6.4%). Yet a much higher (28.66%) HEV IgG seroprevalence was observed among Ghanaian pregnant women, especially pregnant women who were 21–25 years of age and women in their third trimester (Adjei et al., 2009). Furthermore, a high prevalence of HEV infection among pregnant women was reported in their neighboring countries, Egypt (84.3%) (Stoszek et al., 2006), Ethiopia (59%) (Tsega et al., 1993) and during an epidemic in Darfur, Sudan (31.1%; Boccia et al., 2006). Interestingly a low (3.6%) prevalence of anti-HEV IgG was reported in Iran and can be explained by the good hygiene and water supply in the investigated area (Rostamzadeh et al., 2013) and in Mexico (5.7%), where pregnant women of advancing age were more likely to be seropositive for HEV IgG (Alvarado-Esquivel et al., 2014).

In the current study, two of the newborns showed a positive result for anti-HEV IgG. Recently, Mesquita et al. (2013) observed that four pairs (mother and newborn) of participants of the 12 pairs tested were seropositive for anti-HEV IgG. In Egypt, anti-HEV IgG was detected in 31% of 29 neonates with clinical suspicion of congenital infections (El Sayed Zaki et al., 2013). It is worth mentioning that although vertical HEV infection is common and can lead to a high neonatal mortality, HEV is a self-limiting infection in survivors with short-lasting viremia (Khuroo et al., 2009).

Previously (2001), Kumar and colleagues reported 100% transmission of anti-HEV IgG from the mother to the infant and suggested transplacental transmission of IgG. It has been recently demonstrated for the first time that HEV replication occurs in human placenta and that placenta is a proposed site of extrahepatic replication of HEV in humans (Bose et al., 2014). HEV is mainly transmitted by the fecal-oral route, zoonotic transmission from animal reservoirs (including donkeys) to humans, blood borne, human to human, and vertical transmission from mother to child have been reported (Mirazo et al., 2014).

The high seroprevalence of HEV amongst pregnant women in central Sudan may suggest that HEV may be widespread among pregnant women in the country as well as in the general population. Furthermore, because the virus is transmitted mainly through the fecal-oral route, sanitary and hygiene conditions should be in optimum conditions to reduce the risk of infection. Perhaps the policy of not screening for HEV antibodies in pregnant women in Sudan is based on the assumed low prevalence; screening for HEV should be employed based on the results of the current study. Moreover, antenatal screening of pregnant women would ensure that treating clinicians could take further precautions to protect against perinatal HEV transmission, minimizing the risk. One of the limitations of the current study is the failure to investigate the HEV genotyping which should be considered in the future study.

In summary, the current study revealed a high seroprevalence of HEV among pregnant women in central Sudan regardless of their age, parity and gestational age. Optimal preventive measures against HEV infection should be employed.

Data availability

F1000Research: Dataset 1. Raw dataset for Eltayeb et al., 2015 ‘Maternal and newborn seroprevalence of Hepatitis E virus at Medani Hospital, Sudan’, 10.5256/f1000research.7041.d101652

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 16 Sep 2015
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Eltayeb R, Gasim GI, Elhassan EM et al. Maternal and newborn seroprevalence of Hepatitis E virus at Medani Hospital, Sudan [version 1; peer review: 3 approved with reservations]. F1000Research 2015, 4:823 (https://doi.org/10.12688/f1000research.7041.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 16 Sep 2015
Views
6
Cite
Reviewer Report 22 Aug 2016
Shalini Rajaram, Department of Obstetrics and Gynaecology, Guru Tegh Bahadur Hospital, University College of Medical Sciences, New Delhi, Delhi, India 
Approved with Reservations
VIEWS 6
  1. Hepatitis E Infection if it occurs in pregnancy can be acute, fulminant and fatal but mere presence of antibodies does not confer a risk like in Hepatitis B or Hepatitis C infection.
     
... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Rajaram S. Reviewer Report For: Maternal and newborn seroprevalence of Hepatitis E virus at Medani Hospital, Sudan [version 1; peer review: 3 approved with reservations]. F1000Research 2015, 4:823 (https://doi.org/10.5256/f1000research.7579.r15796)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
10
Cite
Reviewer Report 23 Jun 2016
Anna Maria Spera, Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, Naples, Italy 
Vincenzo Bianco, Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, Naples, Italy 
Approved with Reservations
VIEWS 10
In the current manuscript, authors reviewed the seroprevalence of  HEV in mothers and newborns admitted at Medani hospital (Sudan): The paper addresses  a very important issue, since there are few published data on the seroepidemiology on HEV infection in pregnant ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Spera AM and Bianco V. Reviewer Report For: Maternal and newborn seroprevalence of Hepatitis E virus at Medani Hospital, Sudan [version 1; peer review: 3 approved with reservations]. F1000Research 2015, 4:823 (https://doi.org/10.5256/f1000research.7579.r14088)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
8
Cite
Reviewer Report 14 Jun 2016
Stephanie M. Borchardt, Wisconsin Immunization Program, Bureau of Communicable Diseases, Division of Public Health, Wisconsin Department of Health Services, Madison, WI, USA 
Approved with Reservations
VIEWS 8
Abstract
The title is appropriate for the content of the article and the abstract is a suitable summary of the work, though the last sentence of the abstract could include examples of “optimal preventive measures”.
 
Article ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Borchardt SM. Reviewer Report For: Maternal and newborn seroprevalence of Hepatitis E virus at Medani Hospital, Sudan [version 1; peer review: 3 approved with reservations]. F1000Research 2015, 4:823 (https://doi.org/10.5256/f1000research.7579.r14346)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 16 Sep 2015
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.